STOKE THERAPEUTICS INC shareholders Q2 2023

STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 100 filers reported holding STOKE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.8%.

STOKE THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Trexquant Investment LP 47,796$508,0710.01%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 281,800$2,995,5340.01%
Woodline Partners LP 97,024$1,031,3650.01%
BOOTHBAY FUND MANAGEMENT, LLC 43,600$463,4680.01%
GILDER GAGNON HOWE & CO LLC 51,074$542,9170.01%
Schonfeld Strategic Advisors LLC 62,902$668,6480.01%
ALPS ADVISORS INC 32,482$345,2840.00%
Mirae Asset Global Investments Co., Ltd. 133,598$1,420,1460.00%
BOOTHBAY FUND MANAGEMENT, LLC 14,180$150,7330.00%
DEUTSCHE BANK AG\ 570,511$6,064,5320.00%
STATE OF WISCONSIN INVESTMENT BOARD 86,871$923,4390.00%
Man Group plc 96,554$1,026,3690.00%
MORGAN STANLEY 2,921,076$31,051,0380.00%
MILLENNIUM MANAGEMENT LLC 455,115$4,837,8720.00%
China Universal Asset Management Co., Ltd. 579$60.00%
VIRGINIA RETIREMENT SYSTEMS ET AL 15,600$165,8280.00%
FMR LLC 2,325,485$24,719,9050.00%
LOS ANGELES CAPITAL MANAGEMENT LLC 49,077$521,6890.00%
QUADRANT CAPITAL GROUP LLC 1,445$15,3610.00%
Connor, Clark & Lunn Investment Management Ltd. 45,575$484,4620.00%
External links

This page lists STOKE THERAPEUTICS INC's shareholders in Q2 2023. To view STOKE THERAPEUTICS INC's shareholder history, click here.